Downstream Processing Market by Type, Share, Application and Forecast Till 2027

 Downstream Processing Market 2021

According to MRFR analysis, the global downstream processing market is expected to register a CAGR of~16.09% from 2021 to 2027and hold a value of ~USD 61,174.53million by 2027.

Downstream processing refers to the series of operations required to derive pure and homogeneous protein products from biological materials such as cells, tissue culture fluid, or plant tissues. There is a high demand for the end products extracted by downstream processing, owing to the increasing applicationsin biopharmaceutical products. Thus, the downstream processing market is anticipated to observe significant growth during the forecast period.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10670

Major Key Players:

Some of the key players in the global downstream processing market are Thermo Fisher Scientific Inc. (US), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation (US), 3M Company (US), Boehringer Ingelheim (Germany), Lonza Group AG (Switzerland), Eppendorf AG (Switzerland), Corning Incorporated (US), and Asahi Kasei Corporation (Japan).

Segment Analysis

The global downstream processing market has been segmented into technique, product, application, and end user.

By technique, the market has been segregated into cell disruption, solid-liquid separation, clarification/concentration, purification techniques, and formulation. The purification techniques segment is further sub-segmented into ion exchange, affinity exchange, hydrophobic interaction, size exclusion chromatography, and others. The purification techniques segment held a significant share of the market in 2020, as it isone of the vital steps in downstream processing and has high product differentiation.

Based on the product, the global downstream processing market has been classified as chromatography columns &resins, filters, membrane adsorbers, and others. The chromatography columns &resinsis one of the most widely used product andwasestimated to bethe largest segment in 2020.

Based on application, the downstream processing market is segmented into antibiotic production, hormone production, antibodies production, vaccine production, and others. Antibiotic productionis one of the vital applications owing to increasing infectious diseases. Furthermore, the ongoing pandemic has created a huge demand for vaccine production globally which further supports the growth of the market.

Based on the end user, the downstream processing market is segmented into biopharmaceutical manufacturers, contract manufacturing organizations, and others. The biopharmaceutical manufacturers segment held the largest market share in 2020 due to increased R&D activities and production of biologics at a largescale, along with the rapidly growing biopharmaceutical industry.

Regional Analysis

By region, North America is anticipated to dominate the global downstream processing market, owing to well-established research organizations involved in research activities, the presence of a high number of contract manufacturing organizations (CMOs), and the presence of a largenumber of pharmaceutical and biopharmaceutical companies. Moreover, the rise in R&D investments by public and private players in the healthcare sectorfurther drives the market growth.

On the other hand, the European downstream processing market is driven by rising R&D expenditure by biopharmaceutical companies, increasing investments in the R&D sector, and the presence of key market players. For instance, in November 2019, Thermo Fisher Scientific, Inc. (US) announced that it is investing nearly USD 24 million in its Scotland site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell culture media.

Asia-Pacific is anticipated to be the fastest-growing market in the region over the assessment period due to growing and improving healthcare infrastructure, the establishment of research organizations, and increasing investments in biotechnology. In addition, factors such as the growing investments by key market players and the rapidly developing pharma and biopharma sector in the region are further driving the market.For instance, in April 2021, Asahi Kasei Corporation, a solution provider to the biologics manufacturing industry, expanded its business in China with the launch of Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC).The launch of AKBC facilitates business expansion in China by localizing inventory management and order processing for shorter delivery times.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/downstream-processing-market-10670

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Vitamin D Testing Market Overview, Growth Opportunities and Forecast to 2027

 Vitamin D Testing Market 2021

According to MRFR analysis, the global vitamin D testing market is expected to register a CAGR of ~6.1% during the forecast period of 2021 to 2027and is expected to reach USD ~963.6million by 2027

Vitamin D, also referred to as calciferol, is a prohormoneor precursor of a hormone. It is a fat-soluble vitamin that is naturally present in a few foods. Vitamin D is synthesizedwhen ultraviolet rays from sunlight strike the skin.As a response to sun exposure, the human body produces vitamin D. Vitamin D intake can also be boosted through certain foods or supplements.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10665

Major Key Players:

Some of the key players in the global vitamin D testing marketare bioMérieux SA(France), Abbott Laboratories (US), Beckman Coulter (US), Thermo Fisher Scientific (US), Mindray (China), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Corporation (Germany), Quest Diagnostics, Inc. (US), DiaSorin S.p.A. (Italy), Maccura (China), Bio-Rad Laboratories (US), Tosoh Bioscience (Japan), andMerck KGgA (Germany).

Segment Analysis

The global vitamin D testing market has been segmented based ontype, test, application, and end user.

The market, based on type, has been divided into kits, reagents, and instruments. The reagents segment is likely to hold the largest market share in the global vitamin D testing marketdue to its higher usage frequency.

Based on test type, the market has been divided into 25-hydroxy vitamin D test and1, 25-dihydroxy vitamin D test. The 25-hydroxy vitamin D test segment is likely to hold the largest market share in the global vitamin D testing market owing to its larger utility to assess body stores of vitamin D globally.

The vitamin D testing market based on application has been segmented intoclinical testing and research testing. The clinical testing segment is anticipated to hold the largest share in the market due to the huge demand from patients for assessing vitamin deficiency.

The end user segments of the vitamin D testing market are diagnostic laboratories, hospitals & clinicsand home care settings.

Regional Analysis

The market has been divided, by region, into North America, Europe, Asia-Pacific, and the rest of the world.

North America is anticipated to holdthe largest market share owing to a large number of people opting fora vegan diet. An article published in April 2021 assessed the increasing number of people following veganism in the US. A survey found a 300% increase in vegans between 2004 and 2019.In addition, a report found a decrease in meat-eaters from 85% in 2019 to 71% in 2021. The rich sources of vitamin D include milk, eggs, meat, and fish.Thus, an increasing number of vegans in the region is anticipated to boost the number of people suffering from deficiency of Vitamin D. Moreover, a growing number of research studies utilizing vitamin D test kits is expected to propel the market growth in the region during the forecast period. Some of the current examples of ongoing clinical trials include understanding bone mineral density by checking levels of vitamin D at Arkansas Children’s Hospital and absorbance of nano liquid D3via 25(OH)D blood serum test at Inspired Life Medical Office, Minnesota. The vitamin D testing marketin North America is further categorizedinto the US and Canada.

Europe is anticipated to holdasignificant market share owing to a large elderly population and easy availability of products for vitamin D testing.The European vitamin D testing market has been categorized into Germany, France, the UK, Italy, Spain, and the rest of Europe. The clinical research studies associating vitamin D levels with different conditions such as cancer, COVID-19, and certain neurological disorders are expected to increase the requirement for reagents, kits,and equipment required for clinical as well as pre-clinical testing. An article published in MDPI during November 2020, based on a clinical study on COVID-19 patients conducted in France, concluded better survival rates of the elderly population consuming vitamin D supplementation. Aging reduces vitamin D production in the skin. According to the UN’s report World Population Ageing 2017,24.6% of the population of Belgium In 2017 was over 60 years old, and it is projected to increase to 32.4% by the year 2050. Thus, a growing geriatric population, research on vitamin D,and government support for research are anticipated to increase the lucrativeness of the vitamin D testing marketin the region during the forecast period.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/vitamin-d-testing-market-10665

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Endoprosthesis Market: Industry Analysis, Opportunity and Forecast to 2027

 Endoprosthesis Market 2021

The global endoprosthesis market is expected to have a market value of USD 45,134.19 million by 2027.

Endoprosthesis is a surgery that involves using an implant to replace a joint in the body that has lost functionality due to damage or disease, in part or whole. Degenerative joint disease, fractures, and malignancies are all common markers for endoprosthesis use. The growth of the global endoprosthesis is driven by factors such as the increasing prevalence of osteoarthritis among the geriatric population, technological advancements in endoprosthesis devices enabling effective treatment, and increasing awareness among the population. However, adverse effects and high costs associated with endoprosthesis are likely to restrain the market growth.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10658

Major Key Players:

Some of the majorplayers operating in the endoprosthesis market are Johnson & JohnsonServices, Inc.(US), Zimmer Biomet HoldingsInc.(US), Stryker(US), Smith & Nephew(UK), CorinLtd(UK), MedactaInternational SA(Switzerland), Exactech, Inc.(US), MicroPortOrthopedics,Inc.(US), BaumerS.A.(Switzerland), and B. Braun Melsungen AG (Germany).

Segment Analysis

The global endoprosthesis market is segmented into products, further categorized into the knee, hip, shoulder, elbow, finger/hand, and ankle/foot endoprosthesis products. The knee, hip, and shoulder segmentsare further segmented into primary replacement, partial replacement, custom-made replacements, revision replacement, and tumor. The elbow segment is categorized into total elbow replacement, radial head replacement, tumor, and custom-made replacements. The finger/hand segment issegmented into the total wrist, PIP, and MCP finger prosthesis. Lastly, the ankle/foot segment is categorized into the total ankle and great toe implant segments.

Regional Analysis

The global endoprosthesis market, based on region, has been divided into North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

The North American market accounted for the largest share of 29.57% in 2020 and is expected to increase at a CAGR of 11.26% during the forecast period. This is due to the rise in prevalence of knee & hip osteoarthritis among the geriatric population, the presence of key players and lifestyle diseases, technological developments in healthcare applications, and increasing adoption of technically advanced healthcare products.

The South American market held a market share of 14.6% in 2020 and is expected to register a CAGR of 10.38%. Factors like inexpensive treatments, a rise in musculoskeletal diseases, and an increasing geriatric population will drive the market in the forecast period.

Europe accounted for a market share of 24.59% in 2020 and is expected to exhibit a CAGR of 12.41% during the forecast period. Factors such as the increase in the prevalence of joint disorders, improved healthcare infrastructure in the region, the rising geriatric population, and growing awareness about the use of prosthetics in orthopedic injuries are propelling the regional market growth.For instance, according to the Eurostats data published in 2020, 90.4 million older people aged 65 and above were living in the EU-27 in 2019.

Asia-Pacific is expected to register the highest growth rate over the forecast period from 2021to 2027 at a CAGR of 12.78%. Factors like the growing incidence of osteoarthritis and a booming aging population are projected to boost the market growth in the region over the forecast period. In addition, growing expenditure on healthcare infrastructure and rising affordability of the surgery are likely to drive the region’s market growth.

The Middle East & Africa region accounted for a market share of 10.93% in 2020. It is expected to have a CAGR of 9.66% in the forecast period. The market growth is less due to slowly improving economies. However, factors likethe growing aging population and improving healthcare infrastructurewill drive the growth of the endoprosthesis market.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/endoprosthesis-market-10658

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

3D Printing Medical Device Software Market Application - Global Industry Analysis by Size, Share and Forecast 2021 – 2027

 3D Printing Medical Device Software Market 2021

The global 3D Printing Medical Device Software Market  is expected to register a CAGR of 17.62% during the forecast period and is expected to hit USD 657.08 million by 2027.

3D printing medical device software solutions are used to produce medical devices with the help of additive manufacturing. In 3D printing, three-dimensional medical devices are created by adding successive layers of raw materials. Medical devices are produced from a digital 3-D file like Magnetic Resonance Image (MRI) or a Computer-Aided Design (CAD). 3D printing solution is flexible, and it allows designers to make changes without the need for any additional tools. Manufacturers create medical devices matched to a patients’ anatomy. The software used in 3D printing medical devices performs several tasks such as printing, designing, analyzing, visualization, planning, and simulation.

Ongoing technological advancements in software solutions are driving the growth of the3D Printing Medical Device Software Market Application. For a very long time, the 3D printing industry focused on the development of hardware and materials. The recent trend involves a considerable development of software solutions used in the 3D printing of medical devices. The interoperability of software solutions has greatly benefited the 3D printing industry. It has reduced the number of steps, tools, and efforts needed to design a model for printing. Technical advancements have paved the way for the development of innovative 3D-printed products to cater to the growing demand for 3D-printed medical devices in the healthcare industry. As conventional manufacturing processes are time-consuming, key players in the market are focusing on the development of novel products.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/3d-printing-medical-device-software-market-10638

 

Major Key Players:

Some of the key players operating in the 3D Printing Medical Device Software Market are Stratasys Ltd, Nemotec, PS-Medtech, DWS Systems, 3D Systems Corporation, Carima, Real Dimension Inc, Regenhu, 3D Totem, Ackuretta Technologies, and Materialise NV.

Segment Analysis

The global 3D Printing Medical Device Software Market Application, based on type, is segmented into type, function, application, and end user. On the basis of type, the 3D Printing Medical Device Software Market has been sub-segmented into integrated and standalone. On the basis of function, the 3D printing medical devices software market has been segmented into printing, analysis, visualization, planning, design, navigation, and others. On the basis of application, the 3D Printing Medical Device Software Market Application is segmented into medical imaging, dental, surgery, research, physical therapy, aesthetic medicine, and others. Based on end user, the global 3D printing medical devices software market is segmented into medical device companies, dental laboratories, research institutes, hospitals & clinics, and others.

Regional Analysis

The global 3D printing medical devices software market has been segmented on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas 3D printing medical devices software market has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The European 3D printing medical devices software market has been segmented into Western Europe and Eastern Europe. The Western Europe 3D printing medical devices software market has further been classified into Germany, the UK, France, Italy, Spain, and the Rest of Western Europe. The 3D printing medical devices software market in Asia-Pacific has been segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa 3D printing medical devices software market has been divided into the Middle East and Africa.

In 2019, the Americas led the 3D printing medical devices software market with a share of 42.16%, and this trend is expected to continue throughout the forecast period. This is due to the introduction of innovative technologies and their rapid acceptance, as well as the presence of key companies in the region. Moreover, increased research funding from private and public organizations is fueling the market growth in the region.

Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2020 to 2027. Global players are focused on collaboration and opening new offices in the region owing to the availability of talent. For instance, Materialise, a leading US-based 3D printing medical devices software has officially opened a new office in China with a focus on carrying out R&D on 3D printing software. Furthermore, India and China have a number of startups such as think3D and Osteo3d working on the 3D printing medical devices software. These startups are offering services across the world, driving the growth of this region.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cerebral Vascular Stent Market by Type, Share, Application and Forecast Till 2027

 Cerebral Vascular Stent Market 2021

According to MRFR analysis, the global cerebral vascular stent market is expected to register a CAGR of~9.0% from 2021 to 2027.

The global cerebral vascular stent market is driven by several factors, such asthe rising prevalence of cerebral vascular diseases and the booming geriatric population. According to the World Stroke Organization (WSO)’s Global Stroke Fact Sheet 2019, 13 million new cases of stroke are diagnosed globally every year, and over 80 million people who have experienced a stroke are currently living. Furthermore, according to a report published by Mayo Clinic, the US, in May 2019, the most powerful non-modifiable risk factor for incident stroke is aging, and the risk doubles every ten years after the age of 55. Around three-quarters of all strokes occur in those over the age of 65. The frequency of incident strokes in the older population is likely to grow as the number of people aged 65 years rise.

The key players are involved in new product launches, strategic agreements, and acquisitions to strengthen market positions. For instance, in August 2018, Boston Scientific (US) announced an agreement to acquire VENITI, Inc. (US), specializing in venous stent systems. New product approvals by the FDA are supplementing the market growth. For instance, in May 2019, Stryker (US) announced the FDA approval of its brain aneurysm stent system called Neuroform Atlas.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/9147

 

Major Key Players:

Some of the key players in the global cerebral vascular stentmarketareStryker Corporation (US), Boston Scientific Corporation (US), Johnson & Johnson Services, Inc. (US), Terumo Corporation (Japan), Cook Medical (US), Penumbra, Inc. (US), Medtronic plc (Ireland), Acandis GmbH (Germany), Phenox GmbH (Germany), and MicroPort Scientific Corporation (China)among others.

Segment Analysis

The global cerebral vascular stentmarket has been segmented into type and end user.

By type, the market has been segregated into tantalum,stainless steel, and nitinol. The nitinol segment is expected to hold a considerable market share in 2021due to its superior characteristics and wide applications in stents.

Based on end user,the cerebral vascular stentmarket is classified intohospitals, and ambulatory surgical centers. Hospitals held the largest market share in 2020 due toincreasing cerebrovascular disorders across the globe and the need for medical assistance for the same.

Regional Analysis

North America is expected to dominate the cerebral vascular stentmarket in 2021, owing to the increasing health awareness, rising cerebrovascular disorders, technological developments in healthcare applications, and the presence of key players across the region. According to the Brain Aneurysm Foundation data for 2019, an estimated 6.5 million persons in the United States have an unruptured brain aneurysm, or around one in every 50 people. Each year, about 30,000 people in the United States have a brain aneurysm rupture.       

In Europe, the increasing base of the target patient population, namely elderly persons (over the age of 65) and increasing cerebral vascular disorders in the region, are expected to drive the market growth during the study period. According to a report published in July 2020 by King’s College London, by 2047, there will be 2.5 million cases of stroke in Europe, which is a 23% increase from 2017 data.

Asia-Pacific is anticipatedto be the fastest-growing regional market in the forecast period due to factors such asincreasing awareness of clinical outcomes, large population base, rise in geriatric population, and booming cerebral vascular disorders. According to a report by University of Indonesia in November 2020, China had the highest prevalence of stroke in Asia with 1114.8/100 000 persons.

The rest of the world comprises Middle East, Africa, and Latin America. Due to the high rate of acceptance of modern medical devices and the rapid expansion of the healthcare industry in these regions, the cerebral vascular stent market is projected to be a lucrative market in the near future.  

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/cerebral-vascular-stent-market-9147

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Growth Hormone Deficiency Market Research Report - Global Forecast till 2027

 Growth Hormone Deficiency Market 2021

Global Growth Hormone Deficiency Market is expected to have a market value of USD 5,243.3 Million by 2027.

Growth Hormone Deficiency (GHD) is a rare type of disorder where the pituitary gland produces an insufficient secretion of growth hormone in the body. GHD can be congenital or developed in a later stage.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10430

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Growth Hormone Deficiency Market— Novo Nordisk A/S, Eli Lily and Company, Novartis AG, and Merck KGaA, and Pfizer.

Segment Analysis

Global Growth Hormone Deficiency Market is classified into a brand such as Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, and others. In addition, the global growth hormone deficiency market, by application, is segmented into pediatric growth hormone deficiency, Turner syndrome, Idiopathic Short Stature (ISS), small for gestational age, adult growth hormone deficiency, Prader-Willi syndrome, and others. By route of administration, the market is segmented into subcutaneous, intravenous, and intramuscular. The global growth hormone market is segmented by the distribution channel into hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies.

Regional Analysis

Global Growth Hormone Deficiency Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Rest of the World.

The Americas is classified into North America. North America is further categorized into the US Canada and Latin America. The growth hormone deficiency market in the US is expected to hold a major share owing to the growing prevalence of growth hormone deficiency and Turner syndrome, affordability of costly hormonal therapy, and the presence of a well-established healthcare sector.

The European growth hormone deficiency market is categorized into Germany, the UK, France, Italy, Spain, and the rest of Europe. The European market is expected to be the second-largest growth hormone deficiency market. This is attributed to the rising occurrences of growth hormone deficiencies, increasing preference for growth hormones in the treatment of Idiopathic Short Stature (ISS), and rising government expenditure for the healthcare sector. According to the data suggested by the Eurostat, it is observed that among the EU member states, healthcare expenditure in France and Germany was equivalent to 11.3% of the GDP in 2017, a larger share than any other EU member state. The next highest ratio was of Sweden (11.0%).

Asia-Pacific is anticipated to be the fastest-growing market owing to the growing healthcare expenditure and the presence of a large patient pool. Growing investments in the region due to increasing demand are expected to contribute to the market growth. For instance, in March 2017, Novo Nordisk initiated a phase 3 clinical trial of somapacitan (NNC0195-0092) for Adult Growth Hormone Deficiency (AGHD) in Japan. Additionally, the rising awareness about the efficiency of growth hormone therapy in short stature is likely to increase the demand for growth hormone products in this region.

The Middle East and Africa region includes the Middle East & Africa. Increasing healthcare expenditure, rising investments by major market players, and growing patient pool in this region are attributing to the market growth. For instance, according to the International Trade Administration, health expenditure in the UAE was USD 17 billion in 2017 and is likely to reach USD 21.3 billion by 2021.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/growth-hormone-deficiency-market-10430

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Compressed Air Treatment Equipment Market Statistics, Trends, Segmentation Analysis and Forecast to 2027

 Compressed Air Treatment Equipment Market 2021

According to MRFR analysis, Global Compressed Air Treatment Equipment Market is expected to register a CAGR of 6.5 from 2020 to 2027 and hold a value of USD 12,500 Million till 2027.

Global Compressed Air Treatment Equipment Market is driven by several factors, such as high product penetration across various end-use industries such as F&B, pharmaceuticals, chemicals, and others, rising demand from these industries to protect air compressors from corrosion or rust, and technological advancements in the compressed air treatment equipment are augmenting the market growth.

A lot of established and emerging market players are dominating the global compressed air treatment equipment market. The prominent players are involved in strategic agreements, product launches, and joint ventures to sustain their market position. For instance, in May 2017, Atlas Copco (US) acquired Pressure Compressors Ltd (Brazil) and related manufacturers. The acquisition was carried out to help strengthen their presence in both countries, namely Brazil and US.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10343

Major Key Players:

Some of the key players in the global compressed air treatment equipment market are Atlas Copco Corporation (Sweden), Airfilter Engineering (Malaysia), Alpha-Pure (US), Beko Technologies (India), BOGE Compressors (Germany), Chicago Pneumatic (India), Donaldson Company, Inc. (US), Gem Equipment’s Ltd (India), Industrial Air Power (IAP) (UK), Kaeser Compressors, Inc. (Germany), Pneumatech, Inc. (US), Pentair plc. (US), Precision Filtration Products (US), Seneca Companies, Inc. (US), Hitachi Ltd. (Japan), Sullivan-Palatek, Inc. (US), Van Air Systems (US), and Gardner Danver (US).

Segment Analysis

Based on the product, the market has been segregated into filters, dryers, air coolers, and others. The filters segment is expected to gain traction over the forecast period due to its advantages, such as easy-to-use filters, energy efficiency, and provision of safety and flexibility. Furthermore, the dryers segment is expected to be the fastest-growing segment during the forecast period owing to the rise in demand for such devices.

Based on application, the global compressed air treatment equipment market has been classified as plant air/shop air, process air, and instrument air and breathing air. The process air application segment is expected to lead over the forecast period. This is due to the rising demand for compressed air treatment systems across a host of industries, such as pharmaceuticals and which requires a steady supply of clean & oil-free compressed air. The process air segment is anticipated to be the fastest-growing segment owing to the rising use of compressed air treatment equipment for the process air application.

Based on end-use, the F&B segment is expected to be the fastest-growing, and the pharmaceuticals segment held the major share of the market. The global compressed air treatment equipment market is classified as chemicals, F&B, pharmaceuticals, and others. The quality of compressed air in these sectors is of utmost importance as these industries require clean air without any contamination in their operation. Increasing adoption of compressed air treatment equipment by these end-use industries and the presence of regulatory constraints are primarily driving the market growth. On the other hand, the pharmaceuticals segment held the largest share in 2019 owing to the increasing number of pharmaceutical companies using air compressors.

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global compressed air treatment equipment market, owing to the factors such as increasing number of manufacturing facilities, presence of many F&B and pharmaceutical companies, need for optimal energy efficiency, and new technological advancements in products being used in compressed air treatment equipment. Furthermore, regulatory standards such as the ANSI/ISA Instrument Air Standard by the Instrument Society of America equipment aid significantly in the market growth.

 On the other hand, Europe is expected to hold the second position in the global compressed air treatment equipment market due to the favorable regulatory scenario supporting the compressed air treatment procedure and the presence of major giants in the market involved in merger & acquisition, regional expansion, and new product innovation. For instance, in April 2018, Atlas Copco (Sweden) introduced Smart AIR Solutions. These are complete air or gas solutions designed to provide customers with the lowest life cycle costs for their equipment.

Asia-Pacific is anticipated to be the fastest-growing region due to increasing industrialization and urbanization, stringent regulations governing emissions and treatment of industrial effluents, and the need for achieving high efficiency with mechanical equipment and factory processes.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/compressed-air-treatment-equipment-market-10343

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

FFP2 Grade Protective Masks Market - Global Industry Growth, New Opportunities and Forecast – 2027

 FFP2 Grade Protective Masks Market 2021

Global FFP2 Grade Protective Masks Market is expected to have a market value of USD 6,812.03 Million by 2027. An FFP mask, a type of mask certified by the European Union, protects against particulates such as dust particles. It is also called a respiratory protection mask or simply a respirator. The number of reported COVID-19 cases has increased rapidly in several EU countries. Consequently, there have been shortages of personal protective equipment (PPE), in particular, respirators, or filtering face pieces (FFP) categories 2 and 3 (FFP2/FFP3).

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10318

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global FFP2 Grade Protective Masks Market—3M (US), Honeywell (US), Ansell Ltd (Australia), Kimberly-Clark (US), CM Mask (China), Hakugen Earth (Japan), Shanghai Dasheng Health Products Manufacturing Co., Ltd (China), DACH Schutzbekleidung GmbH & Co. KG (Germany), Shanghai YunQing Industrial Co., Ltd (China), Winner Medical (China), and the Gerson Company (US).

Segment Analysis

Global FFP2 Grade Protective Masks Market is segmented based on Type and Application.

The FFP2 grade protective masks market, by type, has been segmented into flat-fold type and cup style. The large share of flat-fold design is due to its benefits, such as saving space and individual packaging.

The global FFP2 grade protective masks market, by application, has been segmented into individual and medical institutions. The individual application segment held the largest share owing to the increase in R&D activities by major research institutions across the world.

Regional Analysis

The global FFP2 grade protective masks market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The FFP2 grade protective masks market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is projected to register the highest CAGR over the forecast period from 2020 to 2027. The outbreak of COVID-19 has increased the production capacity and also encouraged new entrants in the market. For instance, as per the New York Times, Taiwan donated more than 12 million face masks to countries that are severely hit by the pandemic.

The Americas has been segmented into North America and Latin America, with the North American market further divided into the US, Canada, and Mexico. The increasing COVID-19 cases in the region are expected to support the growth of the market. As per the Centers for Disease Control and Prevention (CDC), there were around 2,932,596 cases of coronavirus in the US on July 7, 2020.

The European FFP2 grade protective masks market has been further segmented into Germany, France, the UK, Russia, Italy, and the rest of Western Europe. Increasing strategic initiatives by the prominent players in the market act as an important factor for the growth of the FFP2 masks market in this region. For instance, in May 2020, Honeywell expanded face mask production in Europe with a new manufacturing line in the UK.

The Middle East & Africa FFP2 grade protective masks market is segmented into two major regions, namely the Middle East and Africa. The Middle East market has been further divided into GCC countries, Israel, and Turkey. The growth of the FFP2 grade protective masks market in the Middle East & Africa can be attributed to factors such as the developing healthcare infrastructure, increasing cases of respiratory diseases, and budding medical device industry in the Gulf Cooperation Council (GCC) region.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/ffp2-grade-protective-masks-market-10318

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary POC Diagnostic Market, Get Market Research, Business Risk & Industry Analysis Reports 2027

 Veterinary POC Diagnostic Market 2021

According to MRFR analysis, the Global Veterinary POC Diagnostic Market is expected to register a CAGR of 8.9% during the forecast period of 2020 to 2027 and reach USD 2,894 Million by 2027.

Changes in veterinary healthcare system like Point-of-Care (POC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods.

The growth of the global veterinary POC diagnostic market can be attributed to the growing need for rescue medication, demand for POC diagnostic in the field of veterinary as the diseases in animals is increasing and affecting the human being as well.

Furthermore, growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for pet insurance & growing animal health expenditure, an increasing number of veterinary practitioners, increase in income levels in developed economies are expected to fuel the market growth during the forecast period.

However, the increasing pet care costs and high cost of veterinary imaging instruments are expected to restrain the growth of the global veterinary POC diagnostic market.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/10018

Major Key Players:

Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany)

Segment Analysis

Global Veterinary POC Diagnostic Market has been segmented based on the Product, Technology, Application, Animal Type, and End User.

Based on the type, the global veterinary POC diagnostic market has been segmented into Consumable, Instruments. The consumable segment is expected to hold the largest market share owing to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases.

On the basis of technology, the market has been segmented into Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, and Molecular Diagnostics. Clinical Biochemistry is expected to hold a major market share due to the higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

Based on the application, the market has been segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, and Neurology. Clinical pathology is expected to grow at the fastest CAGR.

The market based on end user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Based on the animal type, the market has been segmented into Companion animals, Livestock Animals. Clinical pathology is expected to grow at the fastest CAGR.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising animal zoonotic diseases in the region. The veterinary POC diagnostic market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European veterinary POC diagnostic market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The veterinary POC diagnostic market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing zoonotic diseases, the market in Asia-Pacific is expected to be the fastest-growing. The veterinary POC diagnostic market in the Middle East & Africa has been divided into the Middle East and Africa.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/veterinary-poc-diagnostic-market-10018

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Insulin Biosimilars Market 2021: Size, Share, Analysis and Forecast-2027

 Insulin Biosimilars Market 2021

According to MRFR analysis, the Global Insulin Biosimilars Market is expected to register a CAGR of 5.4% during the forecast period of 2020 to 2027 to reach USD 3.3 Billion by 2027.

A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed as diabetes. Biosimilar insulin is designed to be highly similar to the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, a number of biosimilar insulin are expected to launch in the coming years.

The USFDA approved new insulin glargine Basaglar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA’s) Biosimilar pathway. Such ongoing approvals by the respective authorities are expected to drive the growth of the insulin biosimilars market. An analysis conducted by the FDA revealed that the US marketed biosimilars typically launched with 15% to 35% lower initial list prices than comparative list prices of reference products. Additionally, even with only 1 generic on the market, list prices can drop by 31% to 39%. The reduction in cost helps patients to adhere to the treatment, thereby increasing the preference for biosimilar products.

FDA hopes to spur insulin biosimilar development with easier clinical trial requirements. In the draft guidance, the agency proposed guidelines reducing the need for clinical trials to test insulin biosimilars for the potential to provoke immune system reactions. Similarly, European regulators stopped recommending immunogenicity trials for insulin biosimilars since 2015.

Get a Sample Request @ https://www.marketresearchfuture.com/reports/insulin-biosimilars-market-9775

Major Key Players:

Some of the key players in the global insulin biosimilars market are Sanofi S.A., Boehringer Ingelheim, Eli Lilly & Co., NOVO Nordisk A/S, Biocon, Merck & Co., Mylan N.V., Pfizer Inc., Sandoz, Fresenius Kabi, and others.

Segment Analysis

The global insulin biosimilars market has been segmented based on type and indication.

The market, based on type, has been divided into rapid-acting biosimilars, long-acting biosimilars, and premixed biosimilars. The long-acting biosimilars are likely to hold maximum market share in the global insulin biosimilars market owing to its benefits in the treatment for diabetes. Pre-mixed insulins are pre-formulated combinations of rapid-acting and long-acting insulin; they provide an approximation of basal/bolus therapy with the advantage of fewer total injection.

Based on indication, the insulin biosimilars market has been bifurcated into type I diabetes and type II diabetes. The type II diabetes segment is anticipated to hold a larger share in the market due to a large number of patients suffering from the condition as compared to type I diabetes.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share owing to the higher number of diagnosed patients undergoing treatment, available healthcare infrastructure, and the presence of prominent players in this region. The insulin biosimilars market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European insulin biosimilars market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The insulin biosimilars market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising prevalence of diabetes and the expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The insulin biosimilars market in the Middle East & Africa has been divided into the Middle East and Africa.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/insulin-biosimilars-market-9775

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com